Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Mel S.
Funding for this research was provided by:
Novartis Foundation (CZOL446HTW07T study)